Inpatient and Outpatient Orderable

NOTCH3 (CADASIL) Sequencing Test

Synonyms

LAB11574
NOTCH3 (CADASIL) SEQUENCING

Cerner Name

Clinical Info

Detects sequence variants in the NOTCH3 gene
in patients with CADASIL (Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy)

Specimen Sources

Blood, Arterial Blood, Capillary Blood, Central Line Blood, Venous

Specimen Types

Blood

Specimen Volume

Container

Lavender Top Tube

Collection Instructions

Container/Tube: 2 Lavender Top Tubes
Specimen: 8 mL Whole Blood ( 6mL min)
Transport Temperature: Room Temperature
Stability: 10 Days Room Temperature or Refrigerated
Unacceptable Frozen
Collection Instructions
Note: Higher blood volumes ensure adequate DNA quantity, which varies with WBC, specimen condition, and need for confirmatory testing.

Transport Instructions

Specimen Stability

10 Days Room Temperature or Refrigerated
Unacceptable Frozen

Methodology

Next Generation Sequencing
This test was developed and its analytical performance characteristics
have been determined by Athena Diagnostics. It has not been cleared
or approved by FDA. This assay has been validated pursuant to the
CLIA regulations and is used for clinical purposes.

Days Performed

TAT: 29 - 36 Days

Performing Laboratory

Athena Diagnostics

CPT

81406
LOINC: Pending assignment

PDM

225991

Only Orderable at Locations:

Orderable Everywhere

Results

Component Name	Base Name	Common Name	External Name
NOTCH3 SEQUENCING	NOTCH3	NOTCH3 SEQUENCING	NOTCH3 (CADASIL) Sequencing

Result Interpretation

See Reference Report

Forms

LAB11574

Search: .supercomplete-item { width: 600px; white-space: nowrap; overflow: hidden; text-overflow: ellipsis; } $(document).ready(function() { $("#search_input").supercomplete(); });